Last reviewed · How we verify
NCT05701345
Study of Virtual Reality-based Medical Device for Patients with Depressive Disorder
NA trial testing OMNIFIT DTx-MDD in Depressive Disorder in 162 participants. Completed in 1 November 2024.
1 November 2024
Quick facts
| Lead sponsor | Omni C&S |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 162 |
| Start date | 9 March 2023 |
| Primary completion | 1 November 2024 |
| Estimated completion | 1 November 2024 |
| Sites | 5 locations across South Korea |
Drugs / interventions tested
- OMNIFIT DTx-MDD
- standard treatment
Conditions studied
- Depressive Disorder — all drugs for Depressive Disorder →
- Major Depressive Disorder — all drugs for Major Depressive Disorder →
- Depressive Episode — all drugs for Depressive Episode →
Sponsor
Omni C&S
Who can join
Adults 19 to 64, any sex, with Depressive Disorder or Major Depressive Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study apply a wearable visual device (HMD)-VR-based software medical device for patients with depressive disorder for 8 weeks. The investigator would like to confirm evaluate the safety and efficacy of the wearable visual device(HMD)-VR-based software medical device effect of improving depressive disorder in patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05701345
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Depressive Disorder
Currently open trials in the same condition.
- NCT07290153 — Psychological State, Immunotherapy Response, and Multi-Omics Signatures in TNBC · recruiting
- NCT07100951 — Comparing Brief Psychoanalytic Couple Therapy and Emotionally Focused Therapy in Reducing Relationship Distress · NA · recruiting
- NCT06890208 — Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures, Third Wave · recruiting
- NCT06901739 — Therapeutic Potential of a Synbiotic to Improve Mental Health in Subjects With Obesity. · NA · recruiting
- NCT06724666 — Transdiagnostic Internet-delivered Intervention for Adolescents With Anxiety and Depression · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05701345 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Omni C&S
- Last refreshed: 4 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05701345.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing